NCT02468284View on ClinicalTrials.gov

Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 13, 2016

Study Completion Date

October 10, 2017

Conditions
Prostate Cancer
Interventions
DRUG

degarelix

Trial Locations (1)

Unknown

Peking University Third Hospital (there may be other sites in this country), Beijing

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY